Grb2 depletion under non-stimulated conditions inhibits PTEN, promotes Akt-induced tumor formation and contributes to poor prognosis in ovarian cancer-Reference-Cited by-同舟云学术

Grb2 depletion under non-stimulated conditions inhibits PTEN, promotes Akt-induced tumor formation and contributes to poor prognosis in ovarian cancer

Published:2015-07-27 Issue:17 Volume:35 Page:2186-2196
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Timsah Z,Ahmed Z,Ivan C^ORCID,Berrout J,Gagea M,Zhou Y,Pena G N A,Hu X,Vallien C,Kingsley C V,Lu Y,Hancock J F,Liu J,Gladden A B,Mills G B,Lopez-Berestein G,Hung M-C,Sood A K,Bogdanov M,Ladbury J E

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2015279.pdf

Reference45 articles.

1. Storz P, Doppler H, Copland JA, Simpson KJ, Toker A . FOXO3a promotes tumor cell invasion through the induction of matrix metalloproteinases. Mol Cell Biol 2009; 29: 4906–4917.

2. Mahbub Hasan AK, Ijiri T, Sato K . Involvement of Src in the adaptation of cancer cells under microenvironmental stresses. J Signal Transduct 2012; 2012: 483796.

3. Risbud MV, Fertala J, Vresilovic EJ, Albert TJ, Shapiro IM . Nucleus pulposus cells upregulate PI3K/Akt and MEK/ERK signaling pathways under hypoxic conditions and resist apoptosis induced by serum withdrawal. Spine 2005; 30: 882–889.

4. Yamamoto N, Mammadova G, Song RXD, Fukami Y, Sato K-i . Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells. J Cell Sci 2006; 119: 4623–4633.

5. Ching JK, Rajguru P, Marupudi N, Banerjee S, Fisher JS . A role for AMPK in increased insulin action after serum starvation. Am J Physiol Cell Physiol 2010; 299: 1171–1179.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GRB2: A dynamic adaptor protein orchestrating cellular signaling in health and disease;Biochemistry and Biophysics Reports;2024-09

2. Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside;Cancers;2024-08-23

3. Affinity purification mass spectrometry characterisation of the interactome of receptor tyrosine kinase proline-rich motifs in cancer;Heliyon;2024-08

4. Affinity purification mass spectrometry characterization of the interactome of receptor tyrosine kinase proline rich motifs in cancer;2024-05-23

5. Transient loss of Polycomb components induces an epigenetic cancer fate;2023-01-04